查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基因克隆服務市場（2021-2031 年）：服務、基因類型、應用、最終用戶、地區
市場調查報告書
商品編碼
1070362

全球基因克隆服務市場（2021-2031 年）：服務、基因類型、應用、最終用戶、地區

Gene Cloning Services Market - A Global and Regional Analysis: Focus on Service, Gene Type, Application, End User, and Region - Analysis and Forecast, 2021-2031
出版日期: | 出版商: BIS Research | 英文 197 Pages | 商品交期: 1-5個工作天內

價格

全球基因克隆服務市場預計將從 2020 年的 19.836 億美元增長到預測期內的 17.29% 的複合年增長率，並在 2031 年增長到 115.224 億美元。

基因合成和克隆服務的有利融資方案、克隆和亞克隆服務的技術進步以及市場協同活動的增加等因素正在推動市場增長。對基因和克隆服務的需求增加、載體和質粒的限制以及新技術和服務的發展也提供了市場增長機會。

本報告調查全球基因克隆服務市場、市場概況、市場上各種影響因素的分析、技術路線圖、法律和監管環境、市場規模轉變/預測、服務/基因型/它總結了各種細分使用情況、最終用戶、地區/主要國家、競爭環境、市場份額、主要公司概況等類別。

目錄

第 1 章市場

第二章調查範圍

第三章調查方法

第 4 章市場概述

  • 基因克隆服務的新用途
  • 可尋址的市場規模和增長潛力
  • COVID-19 對全球基因克隆服務市場的影響

第5章競爭態勢

  • 企業戰略
  • 經營策略
  • 市場份額分析（按公司）
  • 增長份額分析（按公司）

第6章行業分析

  • 美國：法律要求和框架
  • 歐洲：法律要求和框架
  • 亞太地區法律要求和框架

第7章市場動態

  • 概覽
  • 影響分析
  • 市場促進因素
  • 市場製約因素
  • 市場機會

第8章全球基因克隆服務市場：按服務分類

  • 概覽
  • 基因合成服務
  • 分子生物學服務
    • PCR 克隆和亞克隆服務
    • 位點特異性誘變 (SDM)
    • 其他
  • 自定義克隆服務
  • 其他

第 9 章全球基因克隆服務市場：按基因型

  • 概覽
  • 鏈基因
  • 複雜基因
  • 其他

第 10 章全球基因克隆服務市場：按用途

  • 概覽
    • 基因合成
    • 基因表達
    • 基因治療
    • 疫苗研究
    • 其他

第 11 章全球基因克隆服務市場：按最終用戶分類

  • 概覽
    • 學術/研究所
    • 臨床實驗室
    • 製藥和生物技術公司
    • 其他

第 12 章全球基因克隆服務市場：按地區劃分

  • 概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 其他領域

第13章公司簡介

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • GenScript
  • Merck KGaA
  • Takara Bio Inc.
  • Charles River Laboratories
  • Lonza
  • Sartorius AG
  • Creative Biogene
  • Cellecta, Inc.
  • Synbio Technologies
  • TransGen Biotech Co., Ltd.
  • Dobuss(Canvax)
  • Azenta US, Inc.
  • Macrogen, Inc.
  • Codex DNA, Inc.
Product Code: BHP1187SA

“Global Gene Cloning Services Market to Reach $11,524.4 Million by 2031.”

Market Report Coverage - Gene Cloning Services

Market Segmentation

  • Service (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service)
  • Gene Type (Standard Gene, Complex Gene, and Other Gene Type)
  • Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other)
  • End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User)

Regional Segmentation

  • North America: U.S. and Canada
  • Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe
  • Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
  • Latin America: Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World

Market Growth Drivers

  • Favorable Funding Scenario for Gene Synthesis and Cloning Services
  • Technological Advancement in Cloning and Sub Cloning Services
  • Rise in Synergistic Activities in Market

Market Challenges

  • Complications Associated with Large-Scale Production of Cloning Vectors
  • Lower Transfection Efficiency

Market Opportunities

  • Rise in Demand for Gene and Cloning Services
  • Limitation of Vectors or Plasmid
  • Development of New Economical Technologies and Services

Key Companies Profiled

Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc.

Key Questions Answered in this Report:

  • How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
    • Service (gene synthesis service, molecular biology service, custom cloning service, and other service)
    • Gene Type (standard gene, complex gene, and other gene type)
    • Application (gene synthesis, gene expression, vaccine research, gene therapy, and other)
    • End User (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end user)
    • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • What are the major market drivers, challenges, and opportunities in the global gene cloning services market?
  • What are the underlying structures resulting in the emerging trends within the global gene cloning services market?
  • How is each segment of the global gene cloning services market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
  • What are the key developmental strategies implemented by the major players to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for the gene cloning services market?
  • Who are the leading players with significant offerings to the global gene cloning services market? What is the current market dominance for each of these leading players?
  • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which gene cloning service gene type is anticipated to have the most promising growth?
  • What are the key applications in the global gene cloning services market? What are the major segments of these applications? What services are dominating these application segments?
  • What are the major services that are employed in the global gene cloning services market? Which is the dominating service?
  • Who are the primary end users of the global gene cloning services market? Which is the fastest-growing end-user segment in the global gene cloning services market?
  • Who are the key manufacturers in the global gene cloning services market, and what are their contributions? Also, what is the growth potential of each major gene cloning services manufacturer?
  • What is the scope of the global gene cloning services market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which gene cloning service application and end user dominate these regions?
  • What are the emerging trends in the global gene cloning services market? How are these trends revolutionizing the diagnostic procedure?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • What are the regulatory procedures that are required to unify the approval process for emerging gene cloning services? How will these enhance the reimbursement scenario?
  • What are the gaps in regularizing optimum gene cloning services adoption in regular healthcare routines? How can these gaps be tackled?

Market Overview

Gene cloning is an essential part of medical decision-making and aid in acquiring information for a wide range of treatment dissemination, accentuating its criticality in healthcare. Gene cloning has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics.

The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.

Factors fueling the growth of the market include a favorable funding scenario for gene synthesis and cloning services, technological advancement in cloning and subcloning services, and a rise in synergistic activities in the market. Despite rapid advancement in the industry, several key issues need to be addressed to facilitate future growth. Complications associated with large-scale production of cloning vectors and lower transfection efficiency are hampering market growth. Further, some opportunities, such as the rise in demand for gene and cloning services, the limitation of vectors or plasmids, and the development of new economic technologies and services, provide growth to the market.

Within the research report, the market has been segmented on the basis of service, gene type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the regional level has created a buzz among companies to invest in advanced technologies such as gene cloning services.

Based on region, Asia-Pacific holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

Table of Contents

1 Markets

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Data Source
    • 3.1.1 Primary Data Source
      • 3.1.1.1 Primary Research Methodology
    • 3.1.2 Secondary Data Sources
      • 3.1.2.1 Open Sources
  • 3.2 Market Estimation Model
    • 3.2.1 Criteria for Company Profiling

4 Market Overview

  • 4.1 Emerging Applications of Gene Cloning Service
  • 4.2 Addressable Market Size and Growth Potential
  • 4.3 COVID-19 Impact on Global Gene Cloning Services Market
    • 4.3.1 Impact on Market Size

5 Competitive Landscape

  • 5.1 Corporate Strategies
    • 5.1.1 Synergistic Activities
    • 5.1.2 Acquisitions
    • 5.1.3 Business Expansion Activities
  • 5.2 Business Strategies
    • 5.2.1 Service Launches
  • 5.3 Market Share Analysis (by Company)
  • 5.4 Growth-Share Analysis (by Company)

6 Industry Analysis

  • 6.1 Legal Requirements and Framework in the U.S.
    • 6.1.1 FDA Regulations
    • 6.1.2 Legal Requirements and Framework in Europe
      • 6.1.2.1 U.K.
      • 6.1.2.2 Germany
    • 6.1.3 Legal Requirements and Framework in Asia-Pacific
      • 6.1.3.1 China
    • 6.1.4 Japan
      • 6.1.4.1 Pharmaceuticals and Medical Devices Agency (PMDA)

7 Market Dynamics

  • 7.1 Overview
  • 7.2 Impact Analysis
  • 7.3 Market Drivers
    • 7.3.1 Favorable Funding Scenario for Gene Synthesis and Cloning Services
    • 7.3.2 Technological Advancement in Cloning and Sub Cloning Services
    • 7.3.3 Rise in Synergistic Activities in Market
  • 7.4 Market Restraints
    • 7.4.1 Complications Associated with Large-Scale Production of Cloning Vectors
    • 7.4.2 Lower Transfection Efficiency
  • 7.5 Market Opportunities
    • 7.5.1 Rise in Demand for Gene and Cloning Services
    • 7.5.2 Limitation of Vectors or Plasmid
    • 7.5.3 Development of New Economical Technologies and Services

8 Global Gene Cloning Services Market, by Service, $Million, 2020-2031

  • 8.1 Overview
  • 8.2 Gene Synthesis Service
  • 8.3 Molecular Biology Service
    • 8.3.1 PCR Cloning and Sub Cloning Service
    • 8.3.2 Site-Directed Mutagenesis
    • 8.3.3 Other Service
  • 8.4 Custom Cloning Service
  • 8.5 Other Service

9 Global Gene Cloning Services Market, by Gene Type, $Million, 2020-2031

  • 9.1 Overview
  • 9.2 Stranded Gene
  • 9.3 Complex Gene
  • 9.4 Other Gene Type

10 Global Gene Cloning Services Market, by Application, $Million, 2020-2031

  • 10.1 Overview
    • 10.1.1 Gene Synthesis
    • 10.1.2 Gene Expression
    • 10.1.3 Gene Therapy
    • 10.1.4 Vaccine Research
    • 10.1.5 Other

11 Global Gene Cloning Services Market, by End User, $Million, 2020-2031

  • 11.1 Overview
    • 11.1.1 Academic and Research Institutions
    • 11.1.2 Clinical Laboratories
    • 11.1.3 Pharmaceutical and Biotechnology Companies
    • 11.1.4 Other End User

12 Global Gene Cloning Services Market, by Region, $Million, 2020-2031

  • 12.1 Overview
  • 12.2 North America
    • 12.2.1 North America Gene Cloning Services Market (Service)
      • 12.2.1.1 North America Gene Synthesis Service Market
      • 12.2.1.2 North America Molecular Biology Service
      • 12.2.1.3 North America Custom Cloning Service Market
      • 12.2.1.4 North America Other Service Market
    • 12.2.2 U.S.
    • 12.2.3 Canada
  • 12.3 Europe
    • 12.3.1 Europe Gene Cloning Services Market (Service)
      • 12.3.1.1 Europe Gene Synthesis Service Market
      • 12.3.1.2 Europe Molecular Biology Service Market
      • 12.3.1.3 Europe Custom Cloning Service Market
      • 12.3.1.4 Europe Other Service Market
    • 12.3.2 Germany
    • 12.3.3 U.K.
    • 12.3.4 France
    • 12.3.5 Italy
    • 12.3.6 Spain
    • 12.3.7 Switzerland
    • 12.3.8 Rest-of-Europe
  • 12.4 Asia-Pacific
    • 12.4.1 Asia-Pacific Gene Cloning Services Market (Service)
      • 12.4.1.1 Asia-Pacific Gene Synthesis Service Market
      • 12.4.1.2 Asia-Pacific Molecular Biology Service Market
      • 12.4.1.3 Asia-Pacific Custom Cloning Service Market
      • 12.4.1.4 Asia-Pacific Other Service Market
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Japan
    • 12.4.5 Australia
    • 12.4.6 South Korea
    • 12.4.7 Rest-of-Asia-Pacific
  • 12.5 Latin America (LATAM)
    • 12.5.1 Latin America (LATAM) Gene Cloning Services Market (Service)
      • 12.5.1.1 Latin America (LATAM) Gene Synthesis Service Market
      • 12.5.1.2 Latin America (LATAM) Molecular Biology Service Market
      • 12.5.1.3 Latin America (LATAM) Custom Cloning Service Market
      • 12.5.1.4 Latin America (LATAM) Other Service Market
    • 12.5.2 Brazil
    • 12.5.3 Mexico
    • 12.5.4 Rest-of-Latin America
  • 12.6 Rest-of-the-World (RoW)
    • 12.6.1 Rest-of-the-World (RoW) Gene Cloning Services Market (Service)
      • 12.6.1.1 Rest-of-the-World (RoW) Gene Synthesis Service Market
      • 12.6.1.2 Rest-of-the-World (RoW) Molecular Biology Service Market
      • 12.6.1.3 Rest-of-the-World (RoW) Custom Cloning Service Market
      • 12.6.1.4 Rest-of-the-World (RoW) Other Service Market

13 Company Profiles

  • 13.1 Overview
  • 13.2 Thermo Fisher Scientific Inc.
    • 13.2.1 Company Overview
    • 13.2.2 Role of Thermo Fisher Scientific Inc. in the Global Gene Cloning Services Market
    • 13.2.3 Key Customers of the Company
    • 13.2.4 Key Competitors of the Company
    • 13.2.5 Financials
    • 13.2.6 Key Insights about the Financial Health of the Company
    • 13.2.7 SWOT Analysis
  • 13.3 Eurofins Scientific
    • 13.3.1 Company Overview
    • 13.3.2 Role of Eurofins Scientific in the Global Gene Cloning Services Market
    • 13.3.3 Key Customers of the Company
    • 13.3.4 Key Competitors of the Company
    • 13.3.5 Financials
    • 13.3.6 SWOT Analysis
  • 13.4 GenScript
    • 13.4.1 Company Overview
    • 13.4.2 Role of GenScript in the Global Gene Cloning Services Market
    • 13.4.3 Key Customers of the Company
    • 13.4.4 Key Competitors of the Company
    • 13.4.5 Financials
    • 13.4.6 Key Insights about the Financial Health of the Company
    • 13.4.7 SWOT Analysis
  • 13.5 Merck KGaA
    • 13.5.1 Company Overview
    • 13.5.2 Role of Merck KGaA in the Global Gene Cloning Services Market
    • 13.5.3 Key Customers of the Company
    • 13.5.4 Key Competitors of the Company
    • 13.5.5 Financials
    • 13.5.6 Key Insights about the Financial Health of the Company
    • 13.5.7 SWOT Analysis
  • 13.6 Takara Bio Inc.
    • 13.6.1 Company Overview
    • 13.6.2 Role of Takara Bio Inc. in the Global Gene Cloning Services Market
    • 13.6.3 Key Customers of the Company
    • 13.6.4 Key Competitors of the Company
    • 13.6.5 Financials
    • 13.6.6 Key Insights about the Financial Health of the Company
    • 13.6.7 SWOT Analysis
  • 13.7 Charles River Laboratories
    • 13.7.1 Company Overview
    • 13.7.2 Role of Charles River Laboratories in the Global Gene Cloning Services Market
    • 13.7.3 Key Customers of the Company
    • 13.7.4 Key Competitors of the Company
    • 13.7.5 Financials
    • 13.7.6 SWOT Analysis
  • 13.8 Lonza
    • 13.8.1 Company Overview
    • 13.8.2 Role of Lonza in the Global Gene Cloning Services Market
    • 13.8.3 Key Customers of the Company
    • 13.8.4 Key Competitors of the Company
    • 13.8.5 Financials
    • 13.8.6 SWOT Analysis
  • 13.9 Sartorius AG
    • 13.9.1 Company Overview
    • 13.9.2 Role of Sartorius AG in the Global Gene Cloning Services Market
    • 13.9.3 Key Customers of the Company
    • 13.9.4 Key Competitors of the Company
    • 13.9.5 Financials
    • 13.9.6 SWOT Analysis
  • 13.1 Creative Biogene
    • 13.10.1 Company Overview
    • 13.10.2 Role of Creative Biogene in the Global Gene Cloning Services Market
    • 13.10.3 Key Customers of the Company
    • 13.10.4 Key Competitors of the Company
    • 13.10.5 SWOT Analysis
  • 13.11 Cellecta, Inc.
    • 13.11.1 Company Overview
    • 13.11.2 Role of Cellecta, Inc., in the Global Gene Cloning Services Market
    • 13.11.3 Key Customers of the Company
    • 13.11.4 Key Competitors of the Company
    • 13.11.5 SWOT Analysis
  • 13.12 Synbio Technologies
    • 13.12.1 Company Overview
    • 13.12.2 Role of Synbio Technologies in the Global Gene Cloning Services Market
    • 13.12.3 Key Customers of the Company
    • 13.12.4 Key Competitors of the Company
    • 13.12.5 SWOT Analysis
  • 13.13 TransGen Biotech Co., Ltd.
    • 13.13.1 Company Overview
    • 13.13.2 Role of TransGen Biotech Co., Ltd. in the Global Gene Cloning Services Market
    • 13.13.3 Key Customers of the Company
    • 13.13.4 Key Competitors of the Company
    • 13.13.5 SWOT Analysis
  • 13.14 Dobuss (Canvax)
    • 13.14.1 Company Overview
    • 13.14.2 Role of Dobuss (Canvax) in the Global Gene Cloning Services Market.
    • 13.14.3 Key Customers of the Company
    • 13.14.4 Key Competitors of the Company
    • 13.14.5 SWOT Analysis
  • 13.15 Azenta US, Inc.
    • 13.15.1 Company Overview
    • 13.15.2 Role of Azenta US, Inc. in the Global Gene Cloning Services Market
    • 13.15.3 Key Customers of the Company
    • 13.15.4 Key Competitors of the Company
    • 13.15.5 Financials
    • 13.15.6 Key Insights about the Financial Health of the Company
    • 13.15.7 SWOT Analysis
  • 13.16 Macrogen, Inc.
    • 13.16.1 Company Overview
    • 13.16.2 Role of Macrogen, Inc. in the Global Gene Cloning Services Market
    • 13.16.3 Key Customers of the Company
    • 13.16.4 Key Competitors of the Company
    • 13.16.5 SWOT Analysis
  • 13.17 Codex DNA, Inc.
    • 13.17.1 Company Overview
    • 13.17.2 Role of Codex DNA, Inc. in the Global Gene Cloning Services Market
    • 13.17.3 Key Customers of the Company
    • 13.17.4 Key Competitors of the Company
    • 13.17.5 SWOT Analysis

List of Figures

  • Figure 1: Annual NIH Funding in Human Genomics Research, $Billion, FY2013-FY2020
  • Figure 2: Global Gene Cloning Services: Market Dynamics
  • Figure 3: Share of Key Market Strategies and Developments, January 2018-December 2021
  • Figure 4: Global Gene Cloning Services Market Snapshot, $Million, 2020-2031
  • Figure 5: Global Gene Cloning Services Market (by Service), $Million, 2020 Vs. 2031
  • Figure 6: Global Gene Cloning Services Market (by Gene Type), $Million, 2020 Vs. 2031
  • Figure 7: Global Gene Cloning Services Market (by Application), $Million, 2020 Vs. 2031
  • Figure 8: Global Gene Cloning Services Market (by End User), $Million, 2020 Vs. 2031
  • Figure 9: Global Gene Cloning Services Market (by Region), $Million, 2020 Vs. 2031
  • Figure 10: Figure 10: Global Gene Cloning Services Market Segmentation
  • Figure 11: Global Gene Cloning Services Market Research Methodology
  • Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 13: Top-Down Approach (Segment-Wise Analysis)
  • Figure 14: Classification of Gene Cloning Service
  • Figure 15: Personalized Care for Cancer Patients
  • Figure 16: Classification of Gene Cloning Service (by Service)
  • Figure 17: Global Gene Cloning Services Market, $Million, 2020-2031
  • Figure 18: Pre-COVID-19 and Post-COVID-19 Scenario of Global Gene Cloning Services Market, $Million, 2019-2025
  • Figure 19: Impact of COVID-19 on Gene Cloning Services Market
  • Figure 20: Share of Key Developments and Strategies, January 2018-January 2022
  • Figure 21: Share of Synergistic Activities (by Company), January 2018-January 2022
  • Figure 22: Share of Acquisition (by Company), January 2018-January 2022
  • Figure 23: Share of Business Expansion Activities (by Company), January 2018-January 2022
  • Figure 24: Share of Services Launches (by Company), January 2018-January 2022
  • Figure 25: Market Share Analysis for Global Gene Cloning Services Market, $Million, 2019 and 2020
  • Figure 26: Growth-Share Analysis of Global Gene Cloning Services Market (by Company), 2019-2020
  • Figure 27: Responsibilities of the National Medical Products Administration (NMPA)
  • Figure 28: Global Gene Cloning Services Market Dynamics
  • Figure 29: Troubleshooting Guide for Cloning
  • Figure 30: Global Gene Cloning Services Market (by Service)
  • Figure 31: Share of Global Gene Cloning Services Market (by Service), $Million, 2020 and 2031
  • Figure 32: Global Gene Cloning Services Market (Gene Synthesis Service), $Million, 2020-2031
  • Figure 33: Global Gene Cloning Services Market (Molecular Biology Service), $Million, 2020-2031
  • Figure 34: Figure 34: Global Gene Cloning Services Market (PCR Cloning and Sub Cloning Service, by Molecular Biology Service), $Million, 2020-2031
  • Figure 35: Global Gene Cloning Services Market (Site-Directed Mutagenesis, by Molecular Biology Service), $Million, 2020-2031
  • Figure 36: Global Gene Cloning Services Market (Other Service, by Molecular Biology Service), $Million, 2020-2031
  • Figure 37: Global Gene Cloning Services Market (Custom Cloning Service), $Million, 2020-2031
  • Figure 38: Figure 38: Global Gene Cloning Services Market (Other Service), $Million, 2020-2031
  • Figure 39: Global Gene Cloning Services Market (by Gene Type)
  • Figure 40: Share of Global Gene Cloning Services Market (by Gene Type), $Million, 2020 and 2031
  • Figure 41: Global Gene Cloning Services Market (Stranded Gene), $Million, 2020-2031
  • Figure 42: Global Gene Cloning Services Market (Complex Gene), $Million, 2020-2031
  • Figure 43: Global Gene Cloning Services Market (Other Gene Type), $Million, 2020-2031
  • Figure 44: Share of Global Gene Cloning Services Market (by Application), $Million, 2020 and 2031
  • Figure 45: Global Gene Cloning Services Market (Gene Synthesis), $Million, 2020-2031
  • Figure 46: Global Gene Cloning Services Market (Gene Expression), $Million, 2020-2031
  • Figure 47: Global Gene Cloning Services Market (Gene Therapy), $Million, 2020-2031
  • Figure 48: Global Gene Cloning Services Market (Vaccine Research) $Million, 2021-2031
  • Figure 49: Global Gene Cloning Services Market (Other), $Million, 2021-2031
  • Figure 50: Share of Global Gene Cloning Services Market (by End User), $Million, 2020 and 2031
  • Figure 51: Global Gene Cloning Services Market (Academic and Research Institutions), $Million, 2020-2031
  • Figure 52: Global Gene Cloning Services Market (Clinical Laboratories), $Million, 2020-2031
  • Figure 53: Global Gene Cloning Services Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
  • Figure 54: Global Gene Coning Services Market (Other End User), $Million, 2020-2031
  • Figure 55: Global Gene Cloning Services Market (by Region), $Million, 2020-2031
  • Figure 56: Share of North America Gene Cloning Services Market Revenue (by Country), $Million, 2020 and 2031
  • Figure 57: North America: Market Dynamics
  • Figure 58: Share of North America Gene Cloning Services Market Revenue (by Service), $Million, 2020 and 2031
  • Figure 59: North America Gene Synthesis Service Market, $Million, 2020-2031
  • Figure 60: North America Molecular Biology Service Market, $Million, 2020-2031
  • Figure 61: North America Custom Cloning Service Market, $Million, 2020-2031
  • Figure 62: North America Other Service Market, $Million, 2020-2031
  • Figure 63: U.S. Gene Cloning Services Market, $Million, 2020-2031
  • Figure 64: Canada Gene Cloning Services Market, $Million, 2020-2031
  • Figure 65: Europe Gene Cloning Services Market (by Country), $Million, 2020 and 2031
  • Figure 66: Europe: Market Dynamics
  • Figure 67: Europe Gene Cloning Services Market (by Service), $Million, 2020 and 2031
  • Figure 68: Europe Gene Synthesis Service Market, $Million, 2020-2031
  • Figure 69: Europe Molecular Biology Service Market, $Million, 2020-2031
  • Figure 70: Europe Custom Cloning Service Market, $Million, 2020-2031
  • Figure 71: Europe Other Service Market, $Million, 2020-2031
  • Figure 72: Germany Gene Cloning Services Market, $Million, 2020-2031
  • Figure 73: U.K. Gene Cloning Services Market, Million, 2020-2031
  • Figure 74: France Gene Cloning Services Market, $Million, 2020-2031
  • Figure 75: Italy Gene Cloning Services Market, $Million, 2020-2031
  • Figure 76: Spain Gene Cloning Services Market, $Million, 2020-2031
  • Figure 77: Switzerland Gene Cloning Services Market, $Million, 2020-2031
  • Figure 78: Rest-of-Europe Gene Cloning Services Market, $Million, 2020-2031
  • Figure 79: Asia-Pacific: Market Dynamics
  • Figure 80: Asia-Pacific Gene Cloning Services Market (by Country), $Million, 2020 and 2031
  • Figure 81: Asia-Pacific Gene Cloning Services Market (by Service), $Million, 2020 and 2031
  • Figure 82: Asia-Pacific Gene Synthesis Service Market, $Million, 2020-2031
  • Figure 83: Asia-Pacific Molecular Biology Service Market, $Million, 2020-2031
  • Figure 84: Asia-Pacific Custom Cloning Service Market, $Million, 2020-2031
  • Figure 85: Asia-Pacific Other Service Market, $Million, 2020-2031
  • Figure 86: China Gene Cloning Services Market, $Million, 2020-2031
  • Figure 87: India Gene Cloning Services Market, $Million, 2020-2031
  • Figure 88: Japan Gene Cloning Services Market, $Million, 2020-2031
  • Figure 89: Australia Gene Cloning Services Market, $Million, 2020-2031
  • Figure 90: South Korea Gene Cloning Services Market, $Million, 2020-2031
  • Figure 91: Rest-of-Asia-Pacific Gene Cloning Services Market, $Million, 2020-2031
  • Figure 92: Latin America: Market Dynamics
  • Figure 93: Latin America Gene Cloning Services Market (by Country), $Million 2020-2031
  • Figure 94: Latin America Gene Cloning Services Market (by Service), $Million 2020 and 2031
  • Figure 95: Latin America (LATAM) Gene Synthesis Service Market, $Million, 2020-2031
  • Figure 96: Latin America (LATAM) Molecular Biology Service Market, $Million, 2020-2031
  • Figure 97: Latin America (LATAM) Custom Cloning Service Market, $Million, 2020-2031
  • Figure 98: Latin America (LATAM) Other Service Market, $Million, 2020-2031
  • Figure 99: Brazil Gene Cloning Services Market, $Million, 2020-2031
  • Figure 100: Mexico Gene Cloning Services Market, $Million, 2020-2031
  • Figure 101: Rest-of-Latin America Gene Cloning Services Market, $Million, 2020-2031
  • Figure 102: Rest-of-the-World Gene Cloning Services Market, $Million, 2020-2031
  • Figure 103: Rest-of-the-World Gene Cloning Services Market (by Service), $Million, 2020 and 2031
  • Figure 104: Rest-of-the-World (RoW) Gene Synthesis Service Market, $Million, 2020-2031
  • Figure 105: Rest-of-the-World (RoW) Molecular Biology Service Market, $Million, 2020-2031
  • Figure 106: Rest-of-the-World (RoW) Custom Cloning Service Market, $Million, 2020-2031
  • Figure 107: Rest-of-the-World (RoW) Other Service Market, $Million, 2020-2031
  • Figure 108: Share of Key Companies Profiled
  • Figure 109: Thermo Fisher Scientific, Inc.: Service Portfolio
  • Figure 110: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
  • Figure 111: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018-2020
  • Figure 112: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 113: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 114: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 115: Eurofins Scientific: Service Portfolio
  • Figure 116: Eurofins Scientific: Overall Financials, $Million, 2018-2020
  • Figure 117: Eurofins Scientific: Revenue (by Region), $Million, 2018-2020
  • Figure 118: Eurofins Scientific: SWOT Analysis
  • Figure 119: GenScript: Service Portfolio
  • Figure 120: GenScript: Overall Financials, $Million, 2018-2020
  • Figure 121: GenScript: Revenue (by Business Segment), $Million, 2018-2020
  • Figure 122: GenScript: Revenue (by Region), $Million, 2018-2020
  • Figure 123: GenScript: R&D Expenditure, $Million, 2018-2020
  • Figure 124: GenScript: SWOT Analysis
  • Figure 125: Merck KGaA: Service Portfolio
  • Figure 126: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 127: Merck KGaA: Revenue (by Business Segment), $Million, 2019-2021
  • Figure 128: Figure 123 Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 129: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 130: Merck KGaA: SWOT Analysis
  • Figure 131: Takara Bio Inc.: Service Portfolio
  • Figure 132: Takara Bio Inc.: Overall Financials, $Million, 2018-2020
  • Figure 133: Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 134: Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 135: Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021
  • Figure 136: Takara Bio Inc.: SWOT Analysis
  • Figure 137: Charles River Laboratories Service Portfolio
  • Figure 138: Charles River Laboratories: Overall Financials, $Million, 2018-2020
  • Figure 139: Charles River Laboratories: Revenue (by Business Segment), $Million, 2018-2020
  • Figure 140: Charles River Laboratories.: Revenue (by Region), $Million, 2018-2020
  • Figure 141: Charles River Laboratories: SWOT Analysis
  • Figure 142: Lonza: Service Portfolio
  • Figure 143: Lonza: Overall Financials, $Million, 2019-2021
  • Figure 144: Lonza: Revenue (by Business Segment), $Million, 2019-2021
  • Figure 145: Lonza: SWOT Analysis
  • Figure 146: Sartorius AG: Service Portfolio
  • Figure 147: Sartorius AG: Overall Financials, $Million, 2019-2021
  • Figure 148: Sartorius AG: Revenue (by Business Segment), 2019-2021
  • Figure 149: Sartorius AG: Revenue (by Region), $Million, 2019-2021
  • Figure 150: Sartorius AG: SWOT Analysis
  • Figure 151: Creative Biogene: Service Portfolio
  • Figure 152: Creative Biogene.: SWOT Analysis
  • Figure 153: Cellecta, Inc.: Service Portfolio
  • Figure 154: Cellecta, Inc.: SWOT Analysis
  • Figure 155: Synbio Technologies: Service Portfolio
  • Figure 156: Synbio Technologies: SWOT Analysis
  • Figure 157: TransGen Biotech Co., Ltd.: Service Portfolio
  • Figure 158: TransGen Biotech Co., Ltd.: SWOT Analysis
  • Figure 159: Dobuss (Canvax): Service Portfolio
  • Figure 160: Dobuss (Canvax): SWOT Analysis
  • Figure 161: Azenta US, Inc.: Service Portfolio
  • Figure 162: Azenta US, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 163: Azenta US, Inc.: Revenue (by Business Segment), $Million, 2018-2020
  • Figure 164: Azenta US, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 165: Azenta US, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 166: Azenta US, Inc.: SWOT Analysis
  • Figure 167: Macrogen, Inc.: Service Portfolio
  • Figure 168: Macrogen, Inc.: SWOT Analysis
  • Figure 169: Codex DNA, Inc.: Service Portfolio
  • Figure 170: Codex DNA, Inc.: SWOT Analysis

List of Tables

  • Table 1: COVID-19 Impact on Global Gene Cloning Services Market
  • Table 2: Products Launched by Various Key Players for Gene Cloning Services Research
  • Table 3: Companies/Institute Offering Research Grants
  • Table 4: Synergistic Activities Undertaken by Companies in the Global Gene Cloning Services Market
  • Table 5: Efficiency Rate in the Global Gene Cloning Services Market
  • Table 6: Companies Expanding Business in Global Gene Cloning Services Market
  • Table 7: Companies Offering Gene Cloning Services in the Market
  • Table 8: List of Companies Providing Gene Synthesis Service
  • Table 9: List of Companies Providing Molecular Biology Service
  • Table 10: List of Companies Providing Custom Cloning Service
  • Table 11: List of Companies Providing Other Service